CClinicalTrials.gg
CompletedNCT06806865PENGUpdated Jun 5, 2025

Comparison of Continuous Fascia Iliaca Compartment Block With Continuous PENG Block in Total Hip Replacement Cases

An interventional study of Periarticular nerve group block (PENG) and Continuous supra-inguinal fascia iliaca compartment block (SIFICB) in Postoperative Pain, Regional Anesthesia and Pain Management, sponsored by Namik Kemal University. Completed at 1 site in Turkey. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-06-05.

Sponsored by Namik Kemal University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 1 year 9 months after the study started (first participant enrolled Mar 2023, registered Dec 2024).
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

Adequate pain management after total hip arthroplasty (THA) is crucial for early ambulation and patient satisfaction. However, due to the hip joint's innervation complexity, the optimal regional analgesia technique for THA remains controversial.

Total hip arthroplasties are critical surgeries that can take steps to improve the quality of life and functional status of patients who do not respond to conservative treatments. However, patients may present with intense pain in the immediate postoperative period, resulting in inactivity, increased risk of complications, and greater opioid consumption, resulting in adverse effects and prolonged hospital stay. The challenging management of pain is explained by the complex innervation of the hip joint, in which the articular branches of the femoral, obturator, and accessory obturator nerves are responsible for the sensory innervation of the anterior capsule.

This randomized clinical trial compares the analgesic efficacy of FICB and PENG block following THA. Our preliminary results will be postoperative pain scores. As our anesthesia clinic, we routinely perform these known methods after surgery in these cases. Traditional intravenous analgesia methods cause many undesirable side effects depending on the type of opioid used, and they are insufficient compared to regional anesthesia methods.

Read the detailed description

The pericapsular nerve group (PENG) block has been reported as the first method to target the nerves that supply the hip capsule. Later, several studies said it was more effective than traditional peripheral nerve blocks at treating THA-related postoperative pain. However, a single-injection PENG block is only effective for a limited time. Little evidence supports the efficacy of continuous PENG block for postoperative pain management in THA.

Additional anesthetic techniques, such as peripheral nerve blocks, are part of the multimodal analgesic strategy and are often used to manage acute pain better. Inadequate treatment can lead to a persistent painful condition. Although numerous nerve blocks are available for this purpose, some may fail because they cover only some of the innervation of the anterior hip capsule. The trial hypothesizes that with continuous infusion of the pericapsular nerve group block (PENG block), defined in 2018, the four lateral cutaneous nerve blocks local anesthetic between the thigh-associated psoas muscle tendon plane, and the iliopubic eminence will provide adequate analgesia without causing a motor block. Compared to the infrainguinal approach, the fascia iliaca compartment block (FICB) provides better dissemination under the fascia iliaca, while the local anesthetic is administered more cranially. Desmet et al. showed that supra-inguinal FICB reduced morphine consumption and pain scores following THA. However, despite these promising results, obturator nerve block has not been clinically proven.

Total hip arthroplasties are necessary surgeries that can take steps to improve the quality of life and functional status of patients who do not respond to conservative treatments. However, patients may present with intense pain in the immediate postoperative period, resulting in inactivity, increased risk of complications, and greater opioid consumption, resulting in adverse effects and prolonged hospital stay. The challenging management of pain is explained by the complex innervation of the hip joint, in which the articular branches of the femoral, obturator, and accessory obturator nerves are responsible for the sensory innervation of the anterior capsule.

This randomized clinical trial hypothesizes that PENG block will provide better analgesia and result in fewer quadriceps muscle weakness than FICB following THA. Our preliminary results will be postoperative pain scores. Most anesthesia clinics routinely do this by diversifying these methods known after surgery. Traditional intravenous analgesia methods cause many undesirable side effects depending on the type of opioid used, and they are insufficient compared to regional anesthesia methods.

Since THA patients are generally elderly and with comorbidities, regional anesthesia techniques are safer and more effective.

This study focuses on two routine regional anesthesia techniques that can be safely applied. The trial aims to show which of these two methods is more effective.

02

Conditions studied

  • Postoperative Pain
  • Regional Anesthesia
  • Pain Management
  • Total Hip Arthroplasty

Browse trials for

03

In context

Pain, Postoperative

5,093 studies on the registry are indexed under Pain, Postoperative; 1,140 are open to participants now.

This study's enrollment of 60 is below the median of 75 across 4,344 interventional studies indexed under Pain, Postoperative.

Browse Pain, Postoperative studies →

Lead sponsor

Namik Kemal University is the lead sponsor of 57 studies on the registry; 17 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  1. Patients undergoing hip replacement for the first time
  2. Patients aged 18-65 years, ASAI-II (American Society of Anesthesiology classification)
  3. Patients without primary cancer and/or patients without metastatic bone fractures
  4. Patients without allergy to local anaesthetics
  5. Patients with an intellectual level that can use patient-controlled analgesia devices
  6. Patients with a standard bleeding profile
  7. Patients who gave written consent to participate in the study

Exclusion criteria

Exclusion Criteria:

  1. patients who have had a hip replacement and/or revision
  2. patients who have primary cancer and/or fractures due to bone metastasis
  3. patients who have a local anaesthetic allergy and/or a history of it
  4. patients who are not intellectually competent enough to use a patient-controlled anesthesia device
  5. patients who have undergone reoperation due to any surgical complication (bleeding, etc.) within 24 hours after surgery
  6. patients who did not give written consent to participate in the study
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Care provider)
Enrollment
60 participants (actual)

Study arms

  • Active comparator
    PENG Group (periarticular nerve group)

    Continuous PENG block is the group to be applied.

    Procedure: Periarticular nerve group block (PENG)

  • Active comparator
    SIFICB Group (supra-inguinal fascia iliaca compartment block)

    Continuous supra-inguinal fascia iliaca compartment block is the group to be applied.

    Procedure: Continuous supra-inguinal fascia iliaca compartment block (SIFICB)

Interventions

  • ProcedurePeriarticular nerve group block (PENG)

    The pericapsular nerve group (PENG) block targets the nerves that supply the hip capsule. The continuous PENG block will be applied immediately after general anesthesia is given to the participants under ultrasound guidance. 30 ml of 0.25% bupivacaine will be used.

  • ProcedureContinuous supra-inguinal fascia iliaca compartment block (SIFICB)

    The supra-inguinal fascia iliaca compartment block (SIFICB) targets the femoral, lateral femoral cutaneous, and obturator nerves. Under ultrasound guidance, 30 mL of 0.25% bupivacaine is administered, followed by catheter placement for continuous infusion at 5 mL/h.

06

What researchers measure

Primary outcomes

  1. VAS scores

    The Visual Analogue Scale (VAS) measures pain intensity. It consists of a 10 cm line with two endpoints representing 0 ('no pain') and 10 ('pain as bad as it could be'). Ask the patient to rate their current level of pain by placing a mark on the line. VAS scores at rest and during movement will be recorded at 0 hours (PACU), and subsequently at 2, 6, 12, and 24 hours while the patient is in the orthopedic clinic.

    Time frame: up to 24 hours after recovery unit

Secondary outcomes

  1. Total patient-controlled analgesia (PCA) consumption for 24 hours postoperatively

    A patient-controlled analgesia (PCA) pump is a safe way for people in pain to administer intravenous (I.V.) pain medicine (analgesia) when they need it. The pump holds a container filled with pain medicine, allowing the patient to control their pain. A total of 300 mg of tramadol will be used. 3mg/cc.

    Time frame: Up to 24 hours

  2. intraoperative blood pressure

    Blood pressure will be monitored and recorded intermittently throughout the surgery. These parameters may be signs of pain.

    Time frame: from the beginning of anesthesia induction to the leaving the recovery unit

  3. need for additional analgesia or rescue analgesia

    In cases where pain control is inadequate, when the PCA is locked and the VAS score is five or above, additional analgesics are administered. Paracetamol 15 mg/kg will be administered as rescue analgesia in the study.

    Time frame: up to 24 hours after surgery

  4. intraoperative heart rate

    Heart rate will be monitored and recorded intermittently throughout the surgery. These parameters may be signs of pain.

    Time frame: from the beginning of anesthesia induction up to leaving the recovery unit

07

Study locations

1 site
  • Namık Kemal Üniversitesi
    Tekirdağ, Süleymanpasa 59030, Turkey
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 5, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06806865
Lead sponsor
Namik Kemal University
Responsible party
Ayhan ŞAHİN (Assistant Professor, Namik Kemal University) — Principal investigator
First posted
Feb 4, 2025
Start date
Mar 15, 2023
Primary completion
Dec 15, 2024
Completion
Dec 15, 2024
Last update
Jun 5, 2025

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion